Showing results (1771-1780 of 1,784) with videos related to

Sort By:
Pageof 179
Cell Death and Differentiation|May 25, 2021
Patients with COVID-19: in the dark-NETs of neutrophilsMaximilian Ackermann, Hans-Joachim Anders, Rostyslav Bilyy, et al.
The Journal of Clinical Investigation|March 7, 2017
CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosusMohd Hafeez Faridi, Samia Q Khan, Wenpu Zhao, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Cell Death and Differentiation|January 10, 2019
To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular trapsSebastian Boeltz, Poorya Amini, Hans-Joachim Anders, et al.
Science Translational Medicine|February 11, 2021
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responsesYing Kai Chan, Sean K Wang, Colin J Chu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19Carmelo Carmona-Rivera, Yu Zhang, Kerry Dobbs, et al.
JCI Insight|July 19, 2022
Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19Carmelo Carmona-Rivera, Yu Zhang, Kerry Dobbs, et al.
Nature Communications|March 18, 2023
Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndromeAdriana A de Jesus, Guibin Chen, Dan Yang, et al.
Nature Immunology|April 12, 2024
Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiencyHirotsugu Oda, Kalpana Manthiram, Pallavi Pimpale Chavan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2023
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis DiseaseConnie A Haley, Marcos C Schechter, David Ashkin, et al.
Pageof 179